However, a study in an NPM1-mutated transgenic mice model indicated that NPM1 mutation alone is insufficient to initiate leukemia [6], suggesting the need for exploring other underlying oncogenic events in NPM1-mutated AML. The gene discussed is NPM1; the disease is acute myeloid leukemia.